Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (6): 611-615    DOI: 10.19485/j.cnki.issn2096-5087.2022.06.013
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
接种新冠病毒疫苗意愿的影响因素分析
陈剑1, 任飞林2, 郭聪聪3, 林君芬4
1.台州市路桥区疾病预防控制中心传染病防制科,浙江 台州 318050;
2.湖州市疾病预防控制中心,浙江 湖州 316000;
3.台州市椒江区疾病预防控制中心,浙江 台州 318000;
4.浙江省疾病预防控制中心,浙江 杭州 310051
Factors affecting the willingness to receive a COVID-19 vaccination
CHEN Jian1, REN Feilin2, GUO Congcong3, LIN Junfen4
1. Department of Infectious Disease Control and Prevention,Luqiao District Center for Disease Control and Prevention, Taizhou, Zhejiang 318050, China;
2. Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang 316000, China;
3. Jiaojiang District Center for Disease Control and Prevention, Taizhou, Zhejiang 318000, China;
4. Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China
全文: PDF(777 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析浙江省未接种第2剂新型冠状病毒灭活疫苗(新冠灭活疫苗)人群的接种意愿及影响因素,为完善新冠病毒疫苗接种策略提供依据。方法 随机抽取浙江省SaaS化云金苗预防接种系统中2021年3—5月接种第1剂新冠灭活疫苗后超过56 d未接种第2剂的人群(脱漏人员)为调查对象,通过电话调查收集脱漏人员的基本信息、新冠灭活疫苗接种情况和第2剂新冠灭活疫苗接种意愿。采用多因素logistic回归模型分析脱漏人员第2剂新冠灭活疫苗接种意愿的影响因素。结果 调查562人,有效应答292人,有效应答率为51.96%。实际脱漏人员54人,年龄为(40.91±16.75)岁。男性39人,占72.22%;女性15人,占27.78%。初中及以下文化程度为23人,占42.59%。调查时距第1剂新冠灭活疫苗接种时间间隔为(137±28)d。有第2剂新冠灭活疫苗接种意愿27人,占50.00%。多因素logistic回归分析结果显示,工作场所有接种要求的脱漏人员第2剂新冠灭活疫苗接种意愿较高(OR=5.393,95%CI:1.112~26.152);第1剂新冠灭活疫苗接种后感觉身体不适的脱漏人员第2剂新冠灭活疫苗接种意愿较低(OR=0.168,95%CI:0.035~0.806)。结论 本次调查的脱漏人员第2剂新冠灭活疫苗接种意愿较低,工作场所有接种要求和接种第1剂新冠灭活疫苗后未感觉身体不适者第2剂接种意愿较高。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
陈剑
任飞林
郭聪聪
林君芬
关键词 新型冠状病毒疫苗接种意愿影响因素    
AbstractObjective To investigate the willingness to receive a COVID-19 vaccination and its influencing factors among individuals that missed the second dose of the inactivated COVID-19 vaccine in Zhejiang Province, so as to provide the evidence for improving the strategy for COVID-19 vaccination. Methods Individuals that did not receive the second dose of the inactivated COVID-19 vaccine after 56 days of getting the first dose (missed individuals) from March and May, 2021, were randomly sampled from Zhejiang Provincial SaaS Vaccination Information System. Their basic information, status of getting the inactivated COVID-19 vaccine and willingness to receive the second dose of the inactivated COVID-19 vaccine were collected through telephone interviews. The factors affecting the willingness to receive the second dose of the inactivated COVID-19 vaccine were identified among the missed individuals using a multivariable logistic regression model. Results Totally 562 individuals were investigated, and there were 292 (51.96%) valid respondents. There were 54 actual missed individuals, with a mean age of (40.91±16.75) years, which included 39 men (72.22%) and 15 women (27.78%). Of all missed individuals, 23 had an educational level of junior high school and below (42.59%). The mean duration from the time of investigation to the time of getting the first dose of the inactivated COVID-19 vaccine was (137±28) days. A half of the missed individuals were willing to receive the second dose of the inactivated COVID-19 vaccine. Multivariable logistic regression analysis showed high willingness to receive the second dose of the inactivated COVID-19 vaccine among the missed individuals with requirements of vaccination in the workplace (OR=5.393, 95%CI: 1.112-26.152) and low willingness among the missed individuals that felt physical discomfort after receiving the first dose (OR=0.168, 95%CI: 0.035-0.806). Conclusions The willingness to receive the second dose of the inactivated COVID-19 vaccine was low among the missed individuals, and high willingness is seen among the missed individuals with requirements of vaccination in the workplace and without physical discomfort after receiving the first dose of the inactivated COVID-19 vaccine.
Key wordsCOVID-19 vaccine    willingness to vaccination    influencing factor
收稿日期: 2022-02-25      修回日期: 2022-04-22      出版日期: 2022-06-10
中图分类号:  R186  
基金资助:浙江省现场流行病学培训项目
作者简介: 陈剑,本科,主管医师,主要从事传染病防治工作
通信作者: 林君芬,E-mail:jflin@cdc.zj.cn   
引用本文:   
陈剑, 任飞林, 郭聪聪, 林君芬. 接种新冠病毒疫苗意愿的影响因素分析[J]. 预防医学, 2022, 34(6): 611-615.
CHEN Jian, REN Feilin, GUO Congcong, LIN Junfen. Factors affecting the willingness to receive a COVID-19 vaccination. Preventive Medicine, 2022, 34(6): 611-615.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.06.013      或      http://www.zjyfyxzz.com/CN/Y2022/V34/I6/611
[1] 向天新,刘洋,程娜,等.医疗机构工作人员新型冠状病毒疫苗应急接种专家共识[J].中华实验和临床感染病杂志(电子版),2020,14(6):441-446.
XIANG T X,LIU Y,CHENG N,et al.Expert consensus on novel coronavirus vaccine emergency vaccination for staff of medical institutions[J].Chin J Exp Clin Infect Dis,2020,14(6):441-446.
[2] 中华人民共和国国家卫生健康委员会.国务院联防联控机制2022年4月19日新闻发布会文字实录[EB/OL].(2022-04-19)[2022-04-22].http://www.nhc.gov.cn/xcs/s3574/202204/71904942749945c9a460aed122484c3d.shtml.
[3] 中华人民共和国国家卫生健康委员会.新冠病毒疫苗接种技术指南(第一版)[J].中国病毒病杂志,2021,11(3):161-162.
Bureau of Disease Control and Prevention,National Health Commission of the People's Republic of China.Technological Guideline for COVID-19 Vaccination(First edition)[J].Chin J Viral Dis,2021,11(3):161-162.
[4] SAAD-ROY C M,MORRIS S E,METCALF C,et al.Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes[J].MedRxiv,2021,372(6540):363-370.
[5] 郑卫军,何凡.现况调查的样本量计算方法[J].预防医学,2020,32(6):647-648.
ZHENG W J,HE F.Sample size estimate for cross-sectional study[J].Prev Med,2020,32(6):647-648.
[6] 陈瑛玮,许吉祥,王一,等.中国公众COVID-19疫苗选择偏好与接种意愿分析[J].复旦学报:医学版,2021,48(5):578-585,617.
CHEN Y W,XU J X,WANG Y,et al.Public preference and vaccination willingness for COVID-19 vaccine in China[J].Fudan Univ J Med Sci,2021,48(5):578-585,617.
[7] CHEN M,LI Y,CHEN J,et al.An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination[J].Hum Vaccin Immunother,2021,17(7):2279-2288.
[8] 王志伟,李智,黄惠民,等.广州市居民对新型冠状病毒疫苗的认知与接种意愿调查[J].现代预防医学,2021,48(4):732-737.
WANG Z W,LI Z,HUANG H M,et al.Investigation on residents' awareness of COVID-19 vaccines and vaccination willingness in Guangzhou[J].Mod Prev Med,2021,48(4):732-737.
[9] 叶鹏凌,王鸣.关注新型冠状病毒疫苗上市后的热点问题[J].疾病监测,2021,36(4):1-6.
YE P L,WANG M.Hot issues after marketing of COVID-19 vaccine[J].Dis Surveill,2021,36(4):1-6.
[10] 陈宝,陈颖妹,韩花桂,等.海口市门诊患者新冠疫苗接种意愿调查及影响因素分析[J].中国卫生事业管理,2021,38(10):736-739,770.
CHEN B,CHEN Y M,HAN H G,et al.Surveying the willingness of SARS-CoV-2 vaccination among outpatients in Haikou City and its influencing factors[J].Chin Health Serv Manag,2021,38(10):736-739,770.
[11] 王慧莹,郝胜宇,吴相雨,等.江西省常住居民新型冠状病毒疫苗接种意愿和影响因素分析[J].社会科学前沿,2021,10(11):3132-3138.
WANG H Y,HAO S Y,WU X Y,et al.Investigation on the willingness and influencing factors of novel coronavirus vaccine inoculation among residents in Jiangxi Province[J]. Adv Soc Sci,2021,10(11):3132-3138.
[12] 杜智涛,罗湘莹,苏林森.因信而行:信息接触与信任对新冠疫苗接种意愿的影响[J].图书情报知识,2021,38(5):119-133.
DU Z T,LUO X Y,SU L S.Effects of information exposure and trust on COVID-19 vaccination intentions[J].Doc Inf Knowl,2021,38(5):119-133.
[1] 刘晶芝, 胡燕燕, 张学伟, 阿依努尔. 新疆阿勒泰农牧区哈萨克族小学生贫血调查[J]. 预防医学, 2023, 35(9): 807-810.
[2] 朱思懿, 洪航, 边学燕, 许国章. 慢性肾脏病流行病学研究进展[J]. 预防医学, 2023, 35(9): 770-773.
[3] 俞素芬, 蒋青林, 戴杰. 2012—2021年吴兴区新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2023, 35(9): 796-799.
[4] 方柯红, 朱冰, 黄利明, 张旭慧, 刘辉. 杭州市成年居民营养健康知识调查[J]. 预防医学, 2023, 35(8): 710-713.
[5] 周星缘, 洪航, 方挺, 许国章. 肺炎流行病学研究进展[J]. 预防医学, 2023, 35(8): 682-686.
[6] 柏旭, 苏洁, 李凤, 徐倩, 沈源, 肖凌凤. 我国成人糖尿病视网膜病变影响因素的Meta分析[J]. 预防医学, 2023, 35(7): 595-601.
[7] 王梦琴, 柴荟琳, 郭宇燕, 任敬娟, 梁瑞峰. 山西省农村居民高血压防治知识、态度、行为调查[J]. 预防医学, 2023, 35(7): 563-569.
[8] 杨冰声, 曹承建. 杭州市美沙酮维持治疗患者脱失的影响因素分析[J]. 预防医学, 2023, 35(6): 522-525.
[9] 姜海波, 洪航, 周健, 李继革, 史宏博, 谭诗文, 褚堃, 张丹丹. 宁波市HIV/AIDS病例新型毒品使用情况调查[J]. 预防医学, 2023, 35(6): 470-474.
[10] 彭晶, 傅文婷, 杨秀琳. 甘南藏族自治州老年人群健康素养调查[J]. 预防医学, 2023, 35(6): 546-550.
[11] 常倩, 王维丹, 钱建军, 胡华锋. 绍兴市严重精神障碍患者健康体检的影响因素分析[J]. 预防医学, 2023, 35(6): 491-495.
[12] 曾龙武, 唐晓鸿, 张素霞, 刘强, 梁朝聪, 唐漫漫. 结直肠癌化疗患者照护人疾病不确定感影响因素分析[J]. 预防医学, 2023, 35(5): 444-447.
[13] 王倩倩, 章涛, 李傅冬, 林君芬, 何凡, 俞敏, 曹亦菲. 老年人群白内障的影响因素分析[J]. 预防医学, 2023, 35(4): 311-315.
[14] 窦倩如, 黄翠敏, 曹霞, 樊利春. 海南省女性HPV疫苗相关知识和接种意愿调查[J]. 预防医学, 2023, 35(4): 359-364.
[15] 卢小敏, 赵继娟, 孙中友, 张学艳, 陈盛兰. 盐城市儿童青少年健康危险行为聚集情况调查[J]. 预防医学, 2023, 35(4): 331-334.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed